With $2B J&J Deal, FCA Proves It's Still The Anti-Fraud King

By Greg Ryan · November 4, 2013, 8:51 PM EST

The U.S. Department of Justice's $2.2 billion settlement with Johnson & Johnson shows that, despite the recent attention heaped on whistleblower provisions in Dodd-Frank and similar laws, the False Claims Act...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Greg

March 21, 2014
Attys Bash Aetna's Bid For Garlock Asbestos Claimants Info
January 17, 2014
Surgeon General Links Smoking To Diabetes, Liver Cancer
January 10, 2014
Legal Pot Leaves Product Liability Attys Dazed, Confused
December 16, 2013
Stryker Hip Implant Suit Stays In Federal MDL
November 18, 2013
Senate Approves Drug Compounding Reform Bill
October 31, 2013
Tobacco Cos. Lose Bid To Oust Counsel In Canadian Suit
October 29, 2013
UK To Ban Hospitals' Use Of Many Metal Hip Implants
September 19, 2013
4 Ways To Make Sure Comments On Agency Rules Count
August 08, 2013
Compounder Wins Transfer Of Eye Injury Suits To La.
May 24, 2013
JPML Head Judge Explains Why Panel Is More Picky